Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2019-05-28 | 2021-01-31 | 85078 |
| TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2022-08-25 | 2023-09-26 | 167932 |
| ATACAND | 32MG | TABLET | Resolved | 2019-02-06 | 2019-03-14 | 74863 |
| ATACAND | 32MG | TABLET | Resolved | 2020-02-10 | 2020-03-26 | 105632 |
| ATACAND | 32MG | TABLET | Resolved | 2020-06-10 | 2020-06-26 | 117398 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-06-18 | 2020-04-23 | 86963 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 974 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2019-11-28 | 2020-04-23 | 99932 |
| TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120878 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |